Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Inflammatory Response01:28

Inflammatory Response

15.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

11.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.9K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
Inflammation01:38

Inflammation

61.5K
Overview
61.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility of the development and psychometric properties of a standardized screening instrument for mental disorders in patients with suspected rare diseases: results of the ZSE-DUO study.

Frontiers in psychiatry·2025
Same author

Assessing GPT and DeepL for terminology translation in the medical domain: A comparative study on the human phenotype ontology.

BMC medical informatics and decision making·2025
Same author

Enhancing diagnostic precision for rare diseases using case-based reasoning.

Journal of the American Medical Informatics Association : JAMIA·2025
Same author

Mental disorders in people with undiagnosed diseases presenting to German centres for rare diseases - prevalence, type and relevance.

Psychiatry research·2025
Same author

Lentivirus-mediated gene therapy for Fabry disease: 5-year End-of-Study results from the Canadian FACTs trial.

Clinical and translational medicine·2025
Same author

Pareto-principle in rare disease education: assessing the representation of common rare diseases in medical education and coding systems.

Orphanet journal of rare diseases·2024

Related Experiment Videos

Tachykinins in the immune system.

Yu Zhang1, Alexandra Berger, Craig D Milne

  • 1Department of Immunology, Peking University Health Science Center, 38 Xue Yuan Road, Beijing 100083, The People's Republic of China. zhangyu007@bjmu.edu.cn

Current Drug Targets
|August 22, 2006
PubMed
Summary

Newly discovered mammalian tachykinins, like hemokinin 1, may impact immune cell function and inflammatory responses. Further research is crucial for understanding their roles and developing new therapies for immune-mediated diseases.

Related Experiment Videos

Area of Science:

  • Immunology
  • Neuroscience
  • Peptide research

Background:

  • Mammalian tachykinins, including substance P, neurokinin A, and neurokinin B, were previously well-characterized.
  • The recent discovery of hemokinin 1 and other novel tachykinins, predominantly in peripheral tissues, expands this peptide family.
  • The precise influence of these novel tachykinins on the immune system remains largely undetermined.

Purpose of the Study:

  • To investigate the potential roles of newly identified mammalian tachykinins in immune responses.
  • To explore the effects of these peptides on immune cell function and inflammatory processes.
  • To determine if novel tachykinins, similar to traditional ones, modulate immune cell activity.

Main Methods:

  • Literature review and analysis of existing data on tachykinin expression and function.
  • Exploration of preliminary findings suggesting hemokinin 1's role in lymphocyte generation.
  • Comparative analysis of known and novel tachykinin interactions with immune cells.

Main Results:

  • Novel tachykinins are increasingly found in peripheral tissues, suggesting non-neuronal roles.
  • Hemokinin 1 shows potential involvement in lymphocyte development.
  • Tachykinins, traditionally neurotransmitters, are also produced by non-neuronal cells and influence inflammation.

Conclusions:

  • Newly identified tachykinins may play significant roles in modulating immune cell function and inflammatory conditions.
  • Understanding tachykinin-immune cell interactions is vital for developing novel therapeutic strategies for immune and inflammatory diseases.
  • Further research is warranted to elucidate the specific mechanisms and therapeutic potential of these novel peptides.